The Department fully understand that maintaining access to Sabril, enoxaparin and Fosamax is vitally important to many people in this country.
With regards to Sabril, we are aware there have been short term local distribution issues. However, this is expected to be resolved by mid-April with no further issues anticipated.
We are not aware of any issues currently affecting the supply of enoxaparin and Fosamax, and supplies are available.
We continue to work closely with medicine suppliers and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.